Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Cancer Metastatic × Liposomes × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 10 Sarcoma, Kaposi 5 HIV Infections 5 Acquired Immunodeficiency Syndrome 5 Myeloproliferative Disorders 4 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Leukemia, Monocytic, Acute 2 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Rectal Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Biphenotypic, Acute 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Burkitt Lymphoma 1 Breast Neoplasms 1 Breast Cancer Metastatic 1 Advanced Cancer 1

Interventions

Fulvestrant 5 Letrozole 4 exemestane 3 Anastrozole 3 ribociclib 2 dalpiciclib 2 apatinib 2 Gemcitabine 2 Capecitabine 2 tusamitamab ravtansine 1 trastuzumab deruxtecan 1 pyrotinib 1 patritumab deruxtecan 1 palbociclib 1 olaparib 1 nirogacestat 1 margetuximab 1 irinotecan sucrosofate 1 fluzoparib 1 abemaciclib 1 Zoledronic Acid 1 Vinorelbine 1 Trastuzumab 1 Tamoxifen 1 Paclitaxel 1 Neoadjuvant Therapy 1 Liposomes 1 Irinotecan 1 Ga(III)-DOTATOC 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03328884 2025-04-23

Phenomenal

MedSIR

Phase 2 Completed

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡